|
1）Sekirov I, Russell SL, Antunes LC, et al. Gut microbiota in health and disease. Physiol Rev. 2010; 90: 859-904
|
|
|
|
2）Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008; 134: 577-94
|
|
|
|
|
|
3）Magiorakos AP, Suetens C, Boyd L, et al. National hand hygiene campaigns in Europe, 2000-2009. Euro Surveill. 2009; 14. pii: 19190
|
|
|
|
|
|
4）Basu AP, George SM, Udpa G, et al. Spotting the wolf in sheepʼs clothing. Arch Dis Child Educ Pract Ed. 2010; 95: 105-11
|
|
|
|
|
|
5）Ley RE, Turnbaugh PJ, Klein S, et al. Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444: 1022-3
|
|
|
|
|
|
6）Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009; 457: 480-4
|
|
|
|
|
|
7）本田賢也. 腸内フローラに関して何がわかってきたのか．実験医学．2011; 29: 2932-6
|
|
|
|
|
8）Pimentel M. Evaluating a bacterial hypothesis in IBS using a modification of Kochʼs postulates: part 1. Am J Gastroenterol. 2010; 105: 718-21
|
|
|
|
|
|
9）Ford AC, Spiegel BM, Talley NJ, et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009; 7: 1279-86
|
|
|
|
|
|
10）Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010; 16: 2978-90
|
|
|
|
|
|
11）Pimentel M, Lin HC, Enayati P, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. Am J Physiol Gastrointest Liver Physiol. 2006; 290: G1089-95
|
|
|
|
|
|
12）Samuel BS, Shaito A, Motoike T, et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A. 2008; 105: 16767-72
|
|
|
|
|
|
13）Urita Y, Ishihara S, Akimoto T, et al. Seventy-five gram glucose tolerance test to assess carbohydrate malabsorption and small bowel bacterial overgrowth. World J Gastroenterol. 2006; 12: 3092-5
|
|
|
|
|
|
14）Simren M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut. 2006; 55: 297-303
|
|
|
|
|
|
15）El-Matary W, Simpson R, Ricketts-Burns N. Fecal microbiota transplantation: are we opening a can of worms? Gastroenterology. 2012; 143: e19; author reply e19-20
|
|
|
|
|
|
16）Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012; 143: 913-6. e7
|
|
|
|
|
|
17）Andoh A, Imaeda H, Aomatsu T, et al. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohnʼs disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol. 2011; 46: 479-86
|
|
|
|
|
|
18）Gophna U, Sommerfeld K, Gophna S, et al. Differences between tissue-associated intestinal microfloras of patients with Crohnʼs disease and ulcerative colitis. J Clin Microbiol. 2006; 44: 4136-41
|
|
|
|
|
|
19）Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010; 464: 59-65
|
|
|
|
|
|
20）Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009; 15: 1183-9
|
|
|
|
|
|
21）Joossens M, Huys G, Cnockaert M, et al. Dysbiosis of the faecal microbiota in patients with Crohnʼs disease and their unaffected relatives. Gut. 2011; 60: 631-7
|
|
|
|
|
|
22）Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Nat Acad Sci U S A. 2008; 105: 16731-6
|
|
|
|
|
|
23）Willing BP, Dicksved J, Halfvarson J, et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010; 139: 1844-54. e1841
|
|
|
|
|
|
24）Fujimoto T, Imaeda H, Takahashi K, et al. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohnʼs disease. J Gastroenterol hepatol. 2013; 28: 613-9
|
|
|
|
|
|
25）Sartor RB. Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis. Gastroenterology. 2010; 139: 1816-9
|
|
|
|
|
|
26）Png CW, Linden SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 2010; 105: 2420-8
|
|
|
|
|
|
27）Frank DN, Robertson CE, Hamm CM, et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis. 2011; 17: 179-84
|
|
|
|
|
|
28）Hviid A, Svanstrom H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut. 2011; 60: 49-54
|
|
|
|
|
|
29）Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011; 331: 337-41
|
|
|
|
|
|
30）Devkota S, Wang Y, Musch MW, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature. 2012; 487: 104-8
|
|
|
|
|